Operating Lease, Liability in USD of Armata Pharmaceuticals, Inc. from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Armata Pharmaceuticals, Inc. quarterly Operating Lease, Liability history and change rate from Q4 2019 to Q3 2025.
  • Armata Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2025 was $31,362,000.000, a 4.74% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Armata Pharmaceuticals, Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $31,362,000 -$1,561,000 -4.7% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $31,619,000 -$3,133,000 -9% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $31,875,000 -$3,998,000 -11.1% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $32,125,000 -$5,939,000 -15.6% 31 Dec 2024 10-K 21 Mar 2025
Q3 2024 $32,923,000 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $34,752,000 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $35,873,000 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $38,064,000 -$10,751,000 -22% 31 Dec 2023 10-K 21 Mar 2024
Q4 2022 $48,815,000 +$10,826,000 +28.5% 31 Dec 2022 10-K 16 Mar 2023
Q4 2021 $37,989,000 +$25,561,000 +2.1% 31 Dec 2021 10-K 17 Mar 2022
Q4 2020 $12,428,000 +$9,565,000 +3.3% 31 Dec 2020 10-K 18 Mar 2021
Q1 2020 $11,700,000 30 Apr 2020 10-K 21 Mar 2024
Q4 2019 $2,863,000 31 Dec 2019 10-K 19 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.